Epidermal growth factor receptor (EGFR)-mediated adverse events (AEs) in patients (pts) with EGFR mutation positive (EGFR M plus ) non-small cell lung cancer treated with afatinib

臺大醫院;臺大醫學院-腫瘤醫學研究所;Yang, J. Chih-HsinJ. Chih-HsinYangSequist, L.L.SequistO'Byrne, K.K.O'ByrneSchuler, M.M.SchulerMok, T.T.MokGeater, S.S.GeaterMassey, D.D.MasseyO'Brien, D.D.O'BrienZazulina, V.V.ZazulinaWu, Y. L.Y. L.Wu2017-06-272018-07-092017-06-272018-07-092013http://ntur.lib.ntu.edu.tw//handle/246246/280045[SDGs]SDG3Epidermal growth factor receptor (EGFR)-mediated adverse events (AEs) in patients (pts) with EGFR mutation positive (EGFR M plus ) non-small cell lung cancer treated with afatinib